Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients.

ABSTRACT:

Background

Surgery is commonly used to treat stage I lung cancer patients, whereas radiotherapy is applied to treat stage III lung cancer patients. However, few advanced-stage lung cancer patients benefit from surgery. This study aimed to investigate the efficacy of surgery for stage III-N2 non-small cell lung cancer (NSCLC) patients.

Methods

A total of 204 patients with stage III-N2 NSCLC were included and divided into surgery (n=60) and radiotherapy (n=144) groups. The clinical characteristics [tumor node metastasis (TNM) stage, and adjuvant chemotherapy] and basic information (gender, age, and smoking/family history) of the included patients were evaluated. Furthermore, the patients' Eastern Cooperative Oncology Group (ECOG) scores and comorbidities were also evaluated, a

SUBMITTER: Yang J 

PROVIDER: S-EPMC10089857 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature